{"id":259832,"date":"2026-09-21T15:23:19","date_gmt":"2026-09-21T09:53:19","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=259832"},"modified":"2026-10-21T10:34:02","modified_gmt":"2026-10-21T05:04:02","slug":"why-bafnaph-share-price-upper-circuit-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-price-upper-circuit-today-2026\/","title":{"rendered":"Bafna Pharmaceuticals Ltd. Hits Upper Circuit on BSE, 21 October 2026"},"content":{"rendered":"<p>On 21 October 2026, <a href=\"https:\/\/univest.in\/stocks\/bafnaph\/bafna-pharmaceuticals-ltd-share-price-today\">Bafna Pharmaceuticals Ltd.<\/a> (BAFNAPH) hit the upper circuit on BSE at Rs 487.45, a 2% positive move from the previous close of Rs 477.9. The company&#8217;s market cap stood at Rs 1130.54 crore. The upper circuit price for the session was Rs 487.45.<\/p>\n<p>The Bafna Pharmaceuticals upper circuit came as buying interest met the exchange-defined price band. At the time of writing the stock was locked at its upper circuit level, which makes the session worth noting for short-term market participants.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-price-upper-circuit-today-2026\/#Key_Takeaways\" title=\"Key Takeaways\">Key Takeaways<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-price-upper-circuit-today-2026\/#Key_Market_Data\" title=\"Key Market Data\">Key Market Data<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-price-upper-circuit-today-2026\/#Price_Action_and_Trading_Activity\" title=\"Price Action and Trading Activity\">Price Action and Trading Activity<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-price-upper-circuit-today-2026\/#Why_Bafna_Pharmaceuticals_Ltd_Hit_Upper_Circuit\" title=\"Why Bafna Pharmaceuticals Ltd. Hit Upper Circuit\">Why Bafna Pharmaceuticals Ltd. Hit Upper Circuit<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-price-upper-circuit-today-2026\/#What_the_Bafna_Pharmaceuticals_Upper_Circuit_Means\" title=\"What the Bafna Pharmaceuticals Upper Circuit Means\">What the Bafna Pharmaceuticals Upper Circuit Means<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-price-upper-circuit-today-2026\/#Bafna_Pharmaceuticals_Ltd_Fundamentals_and_Valuation\" title=\"Bafna Pharmaceuticals Ltd. Fundamentals and Valuation\">Bafna Pharmaceuticals Ltd. Fundamentals and Valuation<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-price-upper-circuit-today-2026\/#Peer_and_Sector_Context\" title=\"Peer and Sector Context\">Peer and Sector Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-price-upper-circuit-today-2026\/#Technical_Snapshot\" title=\"Technical Snapshot\">Technical Snapshot<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-price-upper-circuit-today-2026\/#What_Readers_Should_Know\" title=\"What Readers Should Know\">What Readers Should Know<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-price-upper-circuit-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-price-upper-circuit-today-2026\/#Why_did_Bafna_Pharmaceuticals_Ltd_hit_upper_circuit_on_21_October_2026\" title=\"Why did Bafna Pharmaceuticals Ltd. hit upper circuit on 21 October 2026?\">Why did Bafna Pharmaceuticals Ltd. hit upper circuit on 21 October 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-price-upper-circuit-today-2026\/#What_was_BAFNAPH_share_price_on_21_October_2026\" title=\"What was BAFNAPH share price on 21 October 2026?\">What was BAFNAPH share price on 21 October 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-price-upper-circuit-today-2026\/#What_was_the_upper_circuit_price_for_BAFNAPH\" title=\"What was the upper circuit price for BAFNAPH?\">What was the upper circuit price for BAFNAPH?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-price-upper-circuit-today-2026\/#What_is_Bafna_Pharmaceuticals_Ltds_market_cap_and_PE_ratio\" title=\"What is Bafna Pharmaceuticals Ltd.&#8217;s market cap and PE ratio?\">What is Bafna Pharmaceuticals Ltd.&#8217;s market cap and PE ratio?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-price-upper-circuit-today-2026\/#Which_exchange_and_data_source_were_used\" title=\"Which exchange and data source were used?\">Which exchange and data source were used?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-price-upper-circuit-today-2026\/#Does_hitting_an_upper_circuit_mean_Bafna_Pharmaceuticals_Ltd_is_a_buy_or_a_sell\" title=\"Does hitting an upper circuit mean Bafna Pharmaceuticals Ltd. is a buy or a sell?\">Does hitting an upper circuit mean Bafna Pharmaceuticals Ltd. is a buy or a sell?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-price-upper-circuit-today-2026\/#Can_you_buy_or_sell_Bafna_Pharmaceuticals_Ltd_shares_when_the_stock_is_at_the_upper_circuit\" title=\"Can you buy or sell Bafna Pharmaceuticals Ltd. shares when the stock is at the upper circuit?\">Can you buy or sell Bafna Pharmaceuticals Ltd. shares when the stock is at the upper circuit?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-price-upper-circuit-today-2026\/#What_happens_the_next_trading_session_after_an_upper_circuit\" title=\"What happens the next trading session after an upper circuit?\">What happens the next trading session after an upper circuit?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-price-upper-circuit-today-2026\/#What_is_the_upper_circuit_limit_set_at_for_Indian_stocks\" title=\"What is the upper circuit limit set at for Indian stocks?\">What is the upper circuit limit set at for Indian stocks?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Key_Takeaways\"><\/span><strong>Key Takeaways<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Bafna Pharmaceuticals Ltd. (BAFNAPH) hit the upper circuit on BSE at Rs 487.45 on 21 October 2026.<\/li>\n<li>The session move was +2% against a previous close of Rs 477.9.<\/li>\n<li>Market capitalisation stood at Rs 1130.54 crore with a PE ratio of 145.16.<\/li>\n<li>No official company announcement or verified catalyst was confirmed at the time of writing.<\/li>\n<li>A price band is an exchange trading rule, not a view on the company or a recommendation.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Key_Market_Data\"><\/span><strong>Key Market Data<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<th>Metric<\/th>\n<th>Value<\/th>\n<\/tr>\n<tr>\n<td>Stock<\/td>\n<td><a href=\"https:\/\/univest.in\/stocks\/bafnaph\/bafna-pharmaceuticals-ltd-share-price-today\">Bafna Pharmaceuticals Ltd.<\/a><\/td>\n<\/tr>\n<tr>\n<td>Current Price \/ LTP<\/td>\n<td>Rs 487.45<\/td>\n<\/tr>\n<tr>\n<td>Day Move<\/td>\n<td>2%<\/td>\n<\/tr>\n<tr>\n<td>Previous Close<\/td>\n<td>Rs 477.9<\/td>\n<\/tr>\n<tr>\n<td>Day Open<\/td>\n<td>Rs 487.45<\/td>\n<\/tr>\n<tr>\n<td>Day High<\/td>\n<td>Rs 487.45<\/td>\n<\/tr>\n<tr>\n<td>Day Low<\/td>\n<td>Rs 487.45<\/td>\n<\/tr>\n<tr>\n<td>Upper Circuit Price<\/td>\n<td>Rs 487.45<\/td>\n<\/tr>\n<tr>\n<td>Upper Circuit Limit<\/td>\n<td>Rs 487.45<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 1130.54 crore<\/td>\n<\/tr>\n<tr>\n<td>Selected Exchange<\/td>\n<td>BSE<\/td>\n<\/tr>\n<tr>\n<td>PE Ratio<\/td>\n<td>145.16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>All figures above are as of 21 October 2026, sourced from Univest market data for the BSE listing. Only fields present in the source for this session are shown.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Price_Action_and_Trading_Activity\"><\/span><strong>Price Action and Trading Activity<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Bafna Pharmaceuticals Ltd. opened at Rs 487.45 on BSE, compared with a previous close of Rs 477.9. During the session, the stock traded between Rs 487.45 and Rs 487.45 before touching the upper circuit price of Rs 487.45.<\/p>\n<p>The absolute day change was Rs 9.55, while the percentage move was 2%. The event figures are kept to a single exchange so the numbers stay comparable.<\/p>\n<p>The selected exchange matters because price bands, day range and previous-close values can differ across exchanges. This article uses BSE consistently for the event table and narrative. The stated upper circuit limit for the session was Rs 487.45, which is the level the price reached.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Bafna_Pharmaceuticals_Ltd_Hit_Upper_Circuit\"><\/span><strong>Why Bafna Pharmaceuticals Ltd. Hit Upper Circuit<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Bafna Pharmaceuticals Ltd. hit the upper circuit after buying interest pushed the stock to its exchange-defined price band. No official company announcement or verified external catalyst was confirmed at the time of writing, so the move should be read primarily through price action and market sentiment.<\/p>\n<p>Because no verified catalyst was available, this article does not attribute the move to earnings, corporate action, sector news, or market rumours. If a confirmed announcement becomes available later, it should be added as a separate update.<\/p>\n<p>Within the session the stock reached the upper circuit level of Rs 487.45.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_the_Bafna_Pharmaceuticals_Upper_Circuit_Means\"><\/span><strong>What the Bafna Pharmaceuticals Upper Circuit Means<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>An upper circuit is the maximum price level a stock is allowed to reach during a trading session under the applicable exchange price band. For Bafna Pharmaceuticals Ltd., the captured upper circuit price was Rs 487.45 on 21 October 2026.<\/p>\n<p>The circuit mechanism is meant to slow extreme price movement and keep trading orderly. It is a market-structure fact, not a return forecast. In this article, the upper circuit explains what happened in the session and where the price band was reached.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Bafna_Pharmaceuticals_Ltd_Fundamentals_and_Valuation\"><\/span><strong>Bafna Pharmaceuticals Ltd. Fundamentals and Valuation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Available market data gives a fuller picture than price action alone. For Bafna Pharmaceuticals Ltd., PE ratio was 145.16, PB ratio was 11.75, book value was Rs 40.68, EPS was 3.29, ROE was 12.27%, ROCE was 11.87%, dividend yield was 0% and debt-to-assets ratio was 0.39, on a market cap of Rs 1130.54 crore. These are available financial indicators and should not be read as a buy, sell, or hold view.<\/p>\n<p>At the reported PB ratio of 11.75, the market valued Bafna Pharmaceuticals Ltd. above its reported book value per share. That premium can reflect growth expectations, asset quality, or simply thin trading in a smaller counter.<\/p>\n<p>For investors tracking upper circuit moves, these metrics help separate the price event from the broader financial profile. A sharp one-day move can attract attention, but valuation and return ratios still need to be reviewed separately.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_and_Sector_Context\"><\/span><strong>Peer and Sector Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Bafna Pharmaceuticals Ltd. belongs to the Pharmaceuticals &amp; Drugs industry within the Healthcare sector. The peer table below uses available companies from the same sector or industry to give broader valuation context.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Peer Company<\/th>\n<th>Market Cap<\/th>\n<th>PE<\/th>\n<th>PB<\/th>\n<th>ROE<\/th>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/solara\/solara-active-pharma-sciences-ltd-share-price-today\">Solara Active Pharma Sciences Ltd.<\/a><\/td>\n<td>Rs 3124.52 crore<\/td>\n<td>84.58<\/td>\n<td>2.18<\/td>\n<td>-0.63%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/indswftlab\/ind-share-price-today\">Ind-Swift Laboratories Ltd.<\/a><\/td>\n<td>Rs 3113.86 crore<\/td>\n<td>54.32<\/td>\n<td>2.17<\/td>\n<td>3.47%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/advenzymes\/advanced-enzyme-technologies-ltd-share-price-today\">Advanced Enzyme Technologies Ltd.<\/a><\/td>\n<td>Rs 2939.37 crore<\/td>\n<td>17.72<\/td>\n<td>1.77<\/td>\n<td>11.43%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/hikal\/hikal-ltd-share-price-today\">Hikal Ltd.<\/a><\/td>\n<td>Rs 2673.16 crore<\/td>\n<td>&#8211;<\/td>\n<td>2.24<\/td>\n<td>-3.97%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/fredun\/fredun-pharmaceuticals-ltd-share-price-today\">Fredun Pharmaceuticals Ltd.<\/a><\/td>\n<td>Rs 2442.82 crore<\/td>\n<td>55.74<\/td>\n<td>8.01<\/td>\n<td>16.09%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>A dash in the PE column means no PE ratio was carried for that company in the source data, which happens when reported earnings are negative or have not been refreshed. Those companies are left out of the average below rather than counted as zero.<\/p>\n<p>Bafna Pharmaceuticals Ltd.&#8217;s PE ratio was 145.16, compared with an available peer PE average of 53.09, calculated from the 4 peer companies that had a PE on record. This comparison is a valuation reference point, not a recommendation.<\/p>\n<div class=\"univest-cta\" style=\"border:1px solid #dbe7f3;background:#f8fbff;padding:18px 22px;border-radius:8px;margin:24px 0;\"><strong>Want to know more?<\/strong> <a href=\"https:\/\/univest.in\/user\/log-in\">Log in to Univest<\/a> for more stock insights.<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Technical_Snapshot\"><\/span><strong>Technical Snapshot<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The technical snapshot adds context: RSI was 67.25, the 50-day moving average was 379.82 and the 200-day moving average was 250.38.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Readers_Should_Know\"><\/span><strong>What Readers Should Know<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The main confirmed fact is that Bafna Pharmaceuticals Ltd. hit the upper circuit on BSE at Rs 487.45 on 21 October 2026, with a 2% day move.<\/p>\n<p>The practical limitation after an upper-circuit session is execution. Buyers queue at the band and sellers step back, so the quoted price is not necessarily a price you can transact at. The other limitation is that no official catalyst was confirmed at the time of writing.<\/p>\n<p>Readers should treat upper circuit events as market updates, not standalone investment conclusions. The price band shows strong near-term interest, but follow-up analysis should consider business fundamentals, valuation, liquidity, risk, and confirmed company disclosures.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_Bafna_Pharmaceuticals_Ltd_hit_upper_circuit_on_21_October_2026\"><\/span><strong>Why did Bafna Pharmaceuticals Ltd. hit upper circuit on 21 October 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The stock reached its upper price band after buying interest during the session. No official company announcement or verified external catalyst was confirmed at the time of writing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_BAFNAPH_share_price_on_21_October_2026\"><\/span><strong>What was BAFNAPH share price on 21 October 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The last traded price used in this article was Rs 487.45 on BSE. That price matched the upper circuit price captured for the event.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_upper_circuit_price_for_BAFNAPH\"><\/span><strong>What was the upper circuit price for BAFNAPH?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The upper circuit price was Rs 487.45. The stated exchange upper circuit limit was Rs 487.45. The event numbers in this article are aligned to BSE.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Bafna_Pharmaceuticals_Ltds_market_cap_and_PE_ratio\"><\/span><strong>What is Bafna Pharmaceuticals Ltd.&#8217;s market cap and PE ratio?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Bafna Pharmaceuticals Ltd.&#8217;s market cap was Rs 1130.54 crore. PE ratio was 145.16.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_exchange_and_data_source_were_used\"><\/span><strong>Which exchange and data source were used?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The selected exchange was BSE. The article uses Univest market data available at the time of generation, captured on 21 October 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Does_hitting_an_upper_circuit_mean_Bafna_Pharmaceuticals_Ltd_is_a_buy_or_a_sell\"><\/span><strong>Does hitting an upper circuit mean Bafna Pharmaceuticals Ltd. is a buy or a sell?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>No. A circuit is an exchange price-band rule that caps how far a stock can move in a single session. It carries no view on valuation or business quality and is not a recommendation. Any decision should rest on fundamentals, valuation, liquidity and your own risk tolerance.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Can_you_buy_or_sell_Bafna_Pharmaceuticals_Ltd_shares_when_the_stock_is_at_the_upper_circuit\"><\/span><strong>Can you buy or sell Bafna Pharmaceuticals Ltd. shares when the stock is at the upper circuit?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>It is usually difficult. At the upper circuit, buy orders queue up while sellers step back, so there may be no counterparty at the quoted price. Orders can stay unfilled until the band opens up or sellers return.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_happens_the_next_trading_session_after_an_upper_circuit\"><\/span><strong>What happens the next trading session after an upper circuit?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>There is no fixed outcome. The band resets each session, so the stock can open freely, hit the same band again, or reverse. The exchange can also revise the applicable band width. The useful signals to watch are whether the company files any disclosure explaining the move.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_upper_circuit_limit_set_at_for_Indian_stocks\"><\/span><strong>What is the upper circuit limit set at for Indian stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Exchange price bands are commonly set at 2%, 5%, 10% or 20% depending on the security, and the applicable band can be revised by the exchange. For Bafna Pharmaceuticals Ltd. the stated limit was Rs 487.45. For this session, Bafna Pharmaceuticals Ltd. moved 2%.<\/p>\n<div style=\"background:#d32f2f;color:#ffffff;padding:16px 20px;border-radius:6px;margin:24px 0;\">\n<p style=\"color:#ffffff;margin:0;\"><strong>Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.<\/p>\n<\/div>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"headline\":\"Bafna Pharmaceuticals Ltd. Hits Upper Circuit on BSE, 21 October 2026\",\"description\":\"Bafna Pharmaceuticals Ltd. hit upper circuit on BSE on 21 October 2026 at Rs 487.45, a 2% move. Price action, valuation and peer context.\",\"datePublished\":\"2026-10-21T05:03:39.424Z\",\"dateModified\":\"2026-10-21T05:03:39.424Z\",\"inLanguage\":\"en-IN\",\"articleSection\":\"Stock Market News\",\"keywords\":\"Bafna Pharmaceuticals upper circuit, Bafna Pharmaceuticals Ltd. share price, BAFNAPH upper circuit, upper circuit stocks today\",\"author\":{\"@type\":\"Organization\",\"name\":\"Univest\",\"url\":\"https:\/\/univest.in\"},\"publisher\":{\"@type\":\"Organization\",\"name\":\"Univest\",\"url\":\"https:\/\/univest.in\"},\"about\":{\"@type\":\"Corporation\",\"name\":\"Bafna Pharmaceuticals Ltd.\",\"tickerSymbol\":\"BAFNAPH\",\"industry\":\"Pharmaceuticals & Drugs\",\"url\":\"https:\/\/univest.in\/stocks\/bafnaph\/bafna-pharmaceuticals-ltd-share-price-today\"},\"mentions\":[{\"@type\":\"Corporation\",\"name\":\"Solara Active Pharma Sciences Ltd.\"},{\"@type\":\"Corporation\",\"name\":\"Ind-Swift Laboratories Ltd.\"},{\"@type\":\"Corporation\",\"name\":\"Advanced Enzyme Technologies Ltd.\"},{\"@type\":\"Corporation\",\"name\":\"Hikal Ltd.\"},{\"@type\":\"Corporation\",\"name\":\"Fredun Pharmaceuticals Ltd.\"}],\"citation\":[]},{\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Why did Bafna Pharmaceuticals Ltd. hit upper circuit on 21 October 2026?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The stock reached its upper price band after buying interest during the session. No official company announcement or verified external catalyst was confirmed at the time of writing.\"}},{\"@type\":\"Question\",\"name\":\"What was BAFNAPH share price on 21 October 2026?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The last traded price used in this article was Rs 487.45 on BSE. That price matched the upper circuit price captured for the event.\"}},{\"@type\":\"Question\",\"name\":\"What was the upper circuit price for BAFNAPH?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The upper circuit price was Rs 487.45. The stated exchange upper circuit limit was Rs 487.45. The event numbers in this article are aligned to BSE.\"}},{\"@type\":\"Question\",\"name\":\"What is Bafna Pharmaceuticals Ltd.'s market cap and PE ratio?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Bafna Pharmaceuticals Ltd.'s market cap was Rs 1130.54 crore. PE ratio was 145.16.\"}},{\"@type\":\"Question\",\"name\":\"Which exchange and data source were used?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The selected exchange was BSE. The article uses Univest market data available at the time of generation, captured on 21 October 2026.\"}},{\"@type\":\"Question\",\"name\":\"Does hitting an upper circuit mean Bafna Pharmaceuticals Ltd. is a buy or a sell?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. A circuit is an exchange price-band rule that caps how far a stock can move in a single session. It carries no view on valuation or business quality and is not a recommendation. Any decision should rest on fundamentals, valuation, liquidity and your own risk tolerance.\"}},{\"@type\":\"Question\",\"name\":\"Can you buy or sell Bafna Pharmaceuticals Ltd. shares when the stock is at the upper circuit?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"It is usually difficult. At the upper circuit, buy orders queue up while sellers step back, so there may be no counterparty at the quoted price. Orders can stay unfilled until the band opens up or sellers return.\"}},{\"@type\":\"Question\",\"name\":\"What happens the next trading session after an upper circuit?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"There is no fixed outcome. The band resets each session, so the stock can open freely, hit the same band again, or reverse. The exchange can also revise the applicable band width. The useful signals to watch are whether the company files any disclosure explaining the move.\"}},{\"@type\":\"Question\",\"name\":\"What is the upper circuit limit set at for Indian stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Exchange price bands are commonly set at 2%, 5%, 10% or 20% depending on the security, and the applicable band can be revised by the exchange. For Bafna Pharmaceuticals Ltd. the stated limit was Rs 487.45. For this session, Bafna Pharmaceuticals Ltd. moved 2%.\"}}]}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Bafna Pharmaceuticals Ltd. hit upper circuit on BSE on 21 October 2026 at Rs 487.45, a 2% move. Price action, valuation and peer context.<\/p>\n","protected":false},"author":35,"featured_media":318746,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-259832","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["318746"],"rank_math_title":["Bafna Pharmaceuticals Upper Circuit Today: Price, Data and Peers"],"rank_math_description":["Bafna Pharmaceuticals Ltd. hit upper circuit on BSE on 21 October 2026 at Rs 487.45, a 2% move. Price action, valuation and peer context."],"rank_math_focus_keyword":["Bafna Pharmaceuticals upper circuit"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/bafna-pharmaceuticals-ltd-hits-upper-circuit-on-bse-21-october-2026.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/259832","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=259832"}],"version-history":[{"count":12,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/259832\/revisions"}],"predecessor-version":[{"id":318749,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/259832\/revisions\/318749"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/318746"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=259832"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=259832"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=259832"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}